Involvement of angiopoietin-like 4 in matrix remodeling during chondrogenic differentiation of mesenchymal stem cells

Journal of Biological Chemistry

Volumn 289, Issue 12, 2014, Pages 8402-8412

  Mathieu, Marc ^a,b   Iampietro, Mathieu ^a,b,d   Chuchana, Paul ^a,b   Guérit, David ^a,b   Djouad, Farida ^a,b   Noël, Danièle ^a,b   Jorgensen, Christian ^a,b,c  

^a HÔPITAL SAINT ELOI   (France)

^b UNIV MONTPELLIER   (France)

^c LAPEYRONIE HOSPITAL   (France)

^d LAVAL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CARTILAGE; COLLAGEN; FLOWCHARTING; GENE ENCODING; GLYCOPROTEINS; MATRIX ALGEBRA; NUCLEIC ACIDS;

CARTILAGE ENGINEERING; CHONDROGENIC DIFFERENTIATION; DIFFERENTIATION PROCESS; MATRIX REMODELING; MESENCHYMAL STEM CELL; METALLOPEPTIDASES; NEUTRALIZING ANTIBODIES; TYPE II COLLAGENS;

CELL CULTURE;

ALPHAVBETA5 INTEGRIN; ANGIOPOIETIN; ANGIOPOIETIN LIKE 4; COLLAGENASE 3; INTERSTITIAL COLLAGENASE; STROMELYSIN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ARTICLE; CARTILAGE MATRIX; CELL DIFFERENTIATION; CHONDROGENESIS; CONTROLLED STUDY; DOWN REGULATION; GENE SEQUENCE; GENE SILENCING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MESENCHYMAL STEM CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SYNTHESIS INHIBITION; RNA INTERFERENCE; UPREGULATION;

CARTILAGE; CELL DIFFERENTIATION; CHONDROCYTES; CHONDROGENESIS; EXTRACELLULAR MATRIX PROTEINS; INTEGRIN; MATRIX METALLOPROTEINASE (MMP); MESENCHYMAL STEM CELLS; TISSUE ENGINEERING; TRANSFORMING GROWTH FACTOR BETA (TGFBETA);

AGGRECANS; ANGIOPOIETINS; CARTILAGE; CELL DIFFERENTIATION; CELLS, CULTURED; CHONDROCYTES; CHONDROGENESIS; COLLAGEN TYPE II; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HUMANS; MESENCHYMAL STROMAL CELLS; RNA INTERFERENCE; TRANSFORMING GROWTH FACTOR BETA; UP-REGULATION;

EID: 84896957736     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M113.539825     Document Type: Article

References (41)

1. Burrage, P. S., Mix, K. S., and Brinckerhoff, C. E. (2006) Matrix metalloproteinases: role in arthritis. Front Biosci. 11, 529-543 (Pubitemid 43258162)
2. Caplan, A. I. (2009) Why are MSCs therapeutic? New data: new insight. J. Pathol. 217, 318-324
3. Jorgensen, C., and Noël, D. (2011) Mesenchymal stem cells in osteoarticular diseases. Regen. Med. 6, 44-51
4. Pittenger, M. F., Mackay, A. M., Beck, S. C., Jaiswal, R. K., Douglas, R., Mosca, J. D., Moorman, M. A., Simonetti, D. W., Craig, S., and Marshak, D. R. (1999) Multilineage potential of adult human mesenchymal stem cells. Science 284, 143-147 (Pubitemid 29282067)
5. Poole, A. R., Kojima, T., Yasuda, T., Mwale, F., Kobayashi, M., and Laverty, S. (2001) Composition and structure of articular cartilage: a template for tissue repair. Clin. Orthop. Relat. Res. 391, S26-33 (Pubitemid 32954010)
6. Pelttari, K., Winter, A., Steck, E., Goetzke, K., Hennig, T., Ochs, B. G., Aigner, T., and Richter, W. (2006) Premature induction of hypertrophy during in vitro chondrogenesis of human mesenchymal stem cells correlates with calcification and vascular invasion after ectopic transplantation in SCID mice. Arthritis Rheum. 54, 3254-3266 (Pubitemid 44622096)
7. Mueller, M. B., and Tuan, R. S. (2008) Functional characterization of hypertrophy in chondrogenesis of human mesenchymal stem cells. Arthritis Rheum. 58, 1377-1388 (Pubitemid 351705927)
8. Knäuper, V., López-Otin, C., Smith, B., Knight, G., and Murphy, G. (1996) Biochemical characterization of human collagenase-3. J. Biol. Chem. 271, 1544-1550 (Pubitemid 26028643)
9. Fosang, A. J., Last, K., Knäuper, V., Murphy, G., and Neame, P. J. (1996) Degradation of cartilage aggrecan by collagenase-3 (MMP-13). FEBS Lett. 380, 17-20 (Pubitemid 26058726)
10. Deng, S. J., Bickett, D. M., Mitchell, J. L., Lambert, M. H., Blackburn, R. K., Carter, H. L., 3rd, Neugebauer, J., Pahel, G., Weiner, M. P., and Moss, M. L. (2000) Substrate specificity of human collagenase 3 assessed using a phage-displayed peptide library. J. Biol. Chem. 275, 31422-31427
11. McCawley, L. J., and Matrisian, L. M. (2001) Matrix metalloproteinases: they're not just for matrix anymore! Curr. Opin. Cell Biol. 13, 534-540 (Pubitemid 32817010)
12. Imai, K., Dalal, S. S., Hambor, J., Mitchell, P., Okada, Y., Horton, W. C., and D'Armiento, J. (2007) Bone growth retardation in mouse embryos expressing human collagenase 1. Am. J. Physiol. Cell Physiol. 293, C1209-C1215 (Pubitemid 47556742)
13. Klein, T., and Bischoff, R. (2011) Physiology and pathophysiology of matrix metalloproteases. Amino Acids 41, 271-290
14. Djouad, F., Bony, C., Häupl, T., Uzé, G., Lahlou, N., Louis-Plence, P., Apparailly, F., Canovas, F., Rème, T., Sany, J., Jorgensen, C., and Noël, D. (2005) Transcriptional profiles discriminate bone marrow-derived and synovium-derived mesenchymal stem cells. Arthritis Res. Ther. 7, R1304-R1315
15. Mrugala, D., Dossat, N., Ringe, J., Delorme, B., Coffy, A., Bony, C., Charbord, P., Häupl, T., Daures, J. P., Noël, D., and Jorgensen, C. (2009) Gene expression profile of multipotent mesenchymal stromal cells: Identification of pathways common to TGFbeta3/BMP2-induced chondrogenesis. Cloning Stem Cells 11, 61-76
16. Chuchana, P., Marchand, D., Nugoli, M., Rodriguez, C., Molinari, N., and Garcia-Sanz, J. A. (2007) An adaptation of the LMS method to determine expression variations in profiling data. Nucleic Acids Res. 35, e71
17. Chuchana, P., Holzmuller, P., Vezilier, F., Berthier, D., Chantal, I., Severac, D., Lemesre, J. L., Cuny, G., Nirdé, P., and Bucheton, B. (2010) Intertwining threshold settings, biological data and database knowledge to optimize the selection of differentially expressed genes from microarray. PLoS One 5, e13518
18. Rozen, S., and Skaletsky, H. J. (2000) Primer3 on the WWW for general users and for biologist programmers in Bioinformatics Methods and Protocols: Methods in Molecular Biology (Krawetz, S., and Misener, S., eds.) pp. 365-386, Humana Press, Totowa, NJ
19. T) method. Methods 25, 402-408 (Pubitemid 34164012)
20. Bouffi, C., Thomas, O., Bony, C., Giteau, A., Venier-Julienne, M. C., Jorgensen, C., Montero-Menei, C., and Noël, D. (2010) The role of pharmacologically active microcarriers releasing TGF-β3 in cartilage formation in vivo by mesenchymal stem cells. Biomaterials 31, 6485-6493
21. Volkmer, E., Drosse, I., Otto, S., Stangelmayer, A., Stengele, M., Kallukalam, B. C., Mutschler, W., and Schieker, M. (2008) Hypoxia in static and dynamic 3D culture systems for tissue engineering of bone. Tissue Eng. Part A 14, 1331-1340
22. Belanger, A. J., Lu, H., Date, T., Liu, L. X., Vincent, K. A., Akita, G. Y., Cheng, S. H., Gregory, R. J., and Jiang, C. (2002) Hypoxia up-regulates expression of peroxisome proliferator-activated receptor γ angiopoietin-related gene (PGAR) in cardiomyocytes: role of hypoxia inducible factor 1alpha. J. Mol. Cell Cardiol. 34, 765-774 (Pubitemid 35205179)
23. Le Jan, S., Amy, C., Cazes, A., Monnot, C., Lamandé, N., Favier, J., Philippe, J., Sibony, M., Gasc, J. M., Corvol, P., and Germain, S. (2003) Angiopoietin-like 4 is a proangiogenic factor produced during ischemia and in conventional renal cell carcinoma. Am. J. Pathol. 162, 1521-1528 (Pubitemid 36512834)
24. Goh, Y. Y., Pal, M., Chong, H. C., Zhu, P., Tan, M. J., Punugu, L., Lam, C. R., Yau, Y. H., Tan, C. K., Huang, R. L., Tan, S. M., Tang, M. B., Ding, J. L., Kersten, S., and Tan, N. S. (2010) Angiopoietin-like 4 interacts with integrins β1 and β5 to modulate keratinocyte migration. Am. J. Pathol. 177, 2791-2803
25. 2 ratio and confers anoikis resistance to tumors. Cancer Cell 19, 401-415
26. Boeuf, S., Graf, F., Fischer, J., Moradi, B., Little, C. B., and Richter, W. (2012) Regulation of aggrecanases from the ADAMTS family and aggrecan neoepitope formation during in vitro chondrogenesis of human mesenchymal stem cells. Eur. Cell Mater. 23, 320-332
27. Sandy, J. D. (2006) A contentious issue finds some clarity: on the independent and complementary roles of aggrecanase activity and MMP activity in human joint aggrecanolysis. Osteoarthritis Cartilage 14, 95-100
28. Chomel, C., Cazes, A., Faye, C., Bignon, M., Gomez, E., Ardidie-Robouant, C., Barret, A., Ricard-Blum, S., Muller, L., Germain, S., and Monnot, C. (2009) Interaction of the coiled-coil domain with glycosaminoglycans protects angiopoietin-like 4 from proteolysis and regulates its antiangiogenic activity. Faseb J. 23, 940-949
29. Goh, Y. Y., Pal, M., Chong, H. C., Zhu, P., Tan, M. J., Punugu, L., Tan, C. K., Huang, R. L., Sze, S. K., Tang, M. B., Ding, J. L., Kersten, S., and Tan, N. S. (2010) Angiopoietin-like 4 interacts with matrix proteins to modulate wound healing. J. Biol. Chem. 285, 32999-33009
30. Murata, M., Yudo, K., Nakamura, H., Chiba, J., Okamoto, K., Suematsu, N., Nishioka, K., Beppu, M., Inoue, K., Kato, T., and Masuko, K. (2009) Hypoxia upregulates the expression of angiopoietin-like-4 in human articular chondrocytes: role of angiopoietin-like-4 in the expression of matrix metalloproteinases and cartilage degradation. J. Orthop. Res. 27, 50-57
31. Mitchell, P. G., Magna, H. A., Reeves, L. M., Lopresti-Morrow, L. L., Yocum, S. A., Rosner, P. J., Geoghegan, K. F., and Hambor, J. E. (1996) Cloning, expression, and type II collagenolytic activity of matrix metalloprotei-nase-13 from human osteoarthritic cartilage. J. Clin. Invest. 97, 761-768 (Pubitemid 26060542)
32. Ståhle-Bäckdahl, M., Sandstedt, B., Bruce, K., Lindahl, A., Jiménez, M. G., Vega, J. A., and López-Otín, C. (1997) Collagenase-3 (MMP-13) is expressed during human fetal ossification and re-expressed in postnatal bone remodeling and in rheumatoid arthritis. Lab. Invest. 76, 717-728
33. Shlopov, B. V., Lie, W. R., Mainardi, C. L., Cole, A. A., Chubinskaya, S., and Hasty, K. A. (1997) Osteoarthritic lesions: involvement of three different collagenases. Arthritis Rheum. 40, 2065-2074 (Pubitemid 27494668)
34. Neuhold, L. A., Killar, L., Zhao, W., Sung, M. L., Warner, L., Kulik, J., Turner, J., Wu, W., Billinghurst, C., Meijers, T., Poole, A. R., Babij, P., and DeGennaro, L. J. (2001) Postnatal expression in hyaline cartilage of constitutively active human collagenase-3 (MMP-13) induces osteoarthritis in mice. J. Clin. Invest. 107, 35-44 (Pubitemid 32047412)
35. Little, C. B., Barai, A., Burkhardt, D., Smith, S. M., Fosang, A. J., Werb, Z., Shah, M., and Thompson, E. W. (2009) Matrix metalloproteinase 13-deficient mice are resistant to osteoarthritic cartilage erosion but not chondrocyte hypertrophy or osteophyte development. Arthritis Rheum. 60, 3723-3733
36. Kennedy, A. M., Inada, M., Krane, S. M., Christie, P. T., Harding, B., López-Otín, C., Sánchez, L. M., Pannett, A. A., Dearlove, A., Hartley, C., Byrne, M. H., Reed, A. A., Nesbit, M. A., Whyte, M. P., and Thakker, R. V. (2005) MMP13 mutation causes spondyloepimetaphyseal dysplasia, Missouri type (SEMD(MO). J. Clin. Invest. 115, 2832-2842 (Pubitemid 41434410)
37. Peake, N. J., Khawaja, K., Myers, A., Jones, D., Cawston, T. E., Rowan, A. D., and Foster, H. E. (2005) Levels of matrix metalloproteinase (MMP)-1 in paired sera and synovial fluids of juvenile idiopathic arthritis patients: relationship to inflammatory activity, MMP-3 and tissue inhibitor of metallopro-teinases-1 in a longitudinal study. Rheumatology 44, 1383-1389 (Pubitemid 41631861)
38. Green, M. J., Gough, A. K., Devlin, J., Smith, J., Astin, P., Taylor, D., and Emery, P. (2003) Serum MMP-3 and MMP-1 and progression of joint damage in early rheumatoid arthritis. Rheumatology 42, 83-88 (Pubitemid 36131572)
39. Hermann, L. M., Pinkerton, M., Jennings, K., Yang, L., Grom, A., Sowders, D., Kersten, S., Witte, D. P., Hirsch, R., and Thornton, S. (2005) Angiopoietin-like-4 is a potential angiogenic mediator in arthritis. Clin. Immunol. 115, 93-101 (Pubitemid 40616175)
40. Geyer, M., Grässel, S., Straub, R. H., Schett, G., Dinser, R., Grifka, J., Gay, S., Neumann, E., and Müller-Ladner, U. (2009) Differential transcriptome analysis of intraarticular lesional vs intact cartilage reveals new candidate genes in osteoarthritis pathophysiology. Osteoarthritis Cartilage 17, 328-335
41. Knowles, H. J., Cleton-Jansen, A. M., Korsching, E., and Athanasou, N. A. (2010) Hypoxia-inducible factor regulates osteoclast-mediated bone resorption: role of angiopoietin-like 4. FASEB J. 24, 4648-4659